Infant Bacterial Therapeutics AB
IBT-B.ST
#9222
Rank
C$0.10 B
Marketcap
$7.62
Share price
-0.56%
Change (1 day)
-30.94%
Change (1 year)

EPS for Infant Bacterial Therapeutics AB (IBT-B.ST)

EPS in 2024 (TTM): -$1.28

According to Infant Bacterial Therapeutics AB's latest financial reports the company's current EPS (TTM) is -$1.31. In 2023 the company made an earnings per share (EPS) of -$1.37 a decrease over its 2022 EPS that were of -$0.78.

EPS history for Infant Bacterial Therapeutics AB from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-$1.28-6.21%
2023-$1.3776.22%
2022-$0.7826.49%
2021-$0.61-43.37%
2020-$1.0877.11%
2019-$0.615.56%
2018-$0.58-43.39%
2017-$1.02-10.87%
2016-$1.15-30.65%
2015-$1.66359.45%
2014-$0.36